Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM)

πŸ“Š End of Day Bhavcopy

Date: 2025-09-09

Price: 238.01
% Change: -0.83% (Prev Close: 240.00)

Volume: 51,831
% Change: -20.94% (Prev Volume: 65,558)

Delivery: 29,101
Delivery % : 56.15
% Change: -22.04% (Prev Delivery: 37,330)

Turnover: 123 Lacs
% Change: -21.51% (Prev Turnover: 157)

πŸ’Ή EOD Valuation

P/E Ratio: 25.98
P/B Ratio: 6.59
Market Cap: 1585 Rs. Cr.

Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: JAGSNPHARM
Market Cap: 1557 Rs. Cr.
Face Value: 2.00 Rs.

52 Week High: 328.04
52 Week Low: 152.34

All-Time High: 328.04 Rs.
All-Time Low: 2.40 Rs.

Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
-10.79% | 7.26% | 12.76% | 43.96% | 17.45%

πŸ‘₯ Shareholding Pattern

Promoter Holding

Promoter Holding: 67.65%

Change (3Y | 1Y): -1.06% | -0.13%

Pledged %: 0.00%

FII Holding

FII Holding: 2.17%

Change (3Y | 1Y): 2.17% | 0.07%

DII Holding

DII Holding: 0.05%

Change (3Y | 1Y): -0.63% | 0.05%

Public Holding: 30.12%

🏦 Financial Strength

Debt to Equity: 0.04
Debt: 9.24 Rs. Cr.

Book Value: 36.14 Rs.
Current Ratio: 6.22
Interest Coverage: 55.21
Free Cash Flow: 90.67 Rs. Cr.

πŸ“ˆ Growth & Sales

Sales Growth: 34.72%

Sales Growth Qtr (YOY | QoQ):
23.06% | 29.12%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
11.13% | 7.29% | 34.72%

πŸ’° Profit & Earnings

Profit Growth %

Profit Growth: 87.26%

Profit Growth Qtr (YOY | QoQ):
38.64% | 64.13%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
38.19% | 29.38% | 87.26%

EPS Rs.

EPS (TTM): 9.16 Rs.

EPS Qtr (Last Year | Latest):
0.81 Rs. | 1.62 Rs.

EPS Annual (Last Annual | Annual March):
3.40 Rs. | 8.34 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
37.82% | 28.80%

Net Profit Rs. Cr.

Net Profit (TTM): 60.83 Rs. Cr.

Net Profit (Annual - March): 55.36 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
5.33| 6.58 | 10.80

EBITDA Rs. Cr.

EBITDA (Quarter): 17.03 Rs. Cr.
EBITDA (Previous Yr Ql): 11.69 Rs. Cr.

EBITDA (Annual - March): 59.26 Rs. Cr.
EBITDA (Previous Annual): 32.34 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
39.87% | 28.76%

πŸ“Š Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 19.46%

OPM Qtr (Previous | Current):
14.87% | 18.78%

OPM Annual (5 Yrs | Last Yr | March):
13.66% | 11.05% | 19.00%

Return on Equity %

ROE: 18.61%

ROE (5 Yrs | 3 Yrs | Last Yr):
16.26% | 17.05% | 12.97%

Return on Capital Employed %

ROCE: 22.95%

ROCE (5 Yrs | 3 Yrs | Last Yr):
20.73% | 21.76% | 16.99%

Return on Assets %

ROA (TTM): 16.05%

ROA (5 Yrs | 3 Yrs | Last Yr):
13.01% | 14.30% | 10.90%

PEG Ratio: 1.24
Dividend Yield: 1.07%

PE 3 Yrs: 38.93
PE 5 Yrs: 35.78

Dividend Yield: 1.07%

πŸ‘₯ Company

Jagsonpal Pharmaceuticals Ltd

JAGSNPHARM

Promoter Holding: %